Novo Nordisk's total assets for Q2 2025 were kr482.15B, a decrease of -1.43% from the previous quarter. DE:NOVA total liabilities were kr314.09B for the fiscal quarter, a -10.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.